Concepedia

Tanja Schneider‐Merck

TS

Statistics

Publications

14

Citations

1.1K

H-Index

13

Active since

2002

Affiliations

Christian-Albrechts-Universität zu Kiel(Current)

Genmab (Netherlands)

University Medical Center Utrecht

Universität Hamburg

Hammersmith Hospital

Tanja Schneider‐Merck is an author at Christian-Albrechts-Universität zu Kiel specializing in oncology, pharmacology, and epidermal growth factor receptor inhibition.

Publications per year

2002–2020

14

Publications

14

Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage

Tanja Schneider‐Merck, Jeroen J. Lammerts van Bueren, Sven Berger et al. · The Journal of Immunology · 2009 · 219 citations · Full text

, , +15

Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells

Matthias Peipp, Jeroen J. Lammerts van Bueren, Tanja Schneider‐Merck et al. · Blood · 2008 · 218 citations · Full text

, , +17

Cyclic AMP-induced Forkhead Transcription Factor, FKHR, Cooperates with CCAAT/Enhancer-binding Protein β in Differentiating Human Endometrial Stromal Cells

Mark Christian, Xiaohui Zhang, Tanja Schneider‐Merck et al. · Journal of Biological Chemistry · 2002 · 181 citations · Full text

, , +14

Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies

Michael Dechant, Wencke Weisner, Sven Berger et al. · Cancer Research · 2008 · 162 citations · Full text

, , +17

Effector Mechanisms of Recombinant IgA Antibodies against Epidermal Growth Factor Receptor

Michael Dechant, Thomas Beyer, Tanja Schneider‐Merck et al. · The Journal of Immunology · 2007 · 89 citations · Full text

, , +13

1–5 of 14